Violich Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$1.23M |
| 2 |
CVS Health
CVS
|
+$497K |
| 3 |
JPMorgan Chase
JPM
|
+$456K |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$298K |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$284K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Long-Term Bond ETF
BLV
|
+$4.93M |
| 2 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$1.82M |
| 3 |
Wells Fargo
WFC
|
+$1.52M |
| 4 |
Apple
AAPL
|
+$1.48M |
| 5 |
Microsoft
MSFT
|
+$1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.04% |
| 2 | Healthcare | 20.96% |
| 3 | Communication Services | 15.06% |
| 4 | Consumer Staples | 12.67% |
| 5 | Financials | 11.67% |
Similar funds
Violich Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Violich Capital Management held 118 positions worth $374M, down 18% from $458M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Violich Capital Management withdrew a net $19M in Q1 2020, closing 18 positions and reducing 47 holdings. Its most notable exit was Vanguard Long-Term Bond ETF, an estimated $4.93M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Violich Capital Management opened a new position in Mastercard worth $1M.
- Violich Capital Management's largest Q1 2020 buy was Mastercard: 4,150 shares worth $1M.
- Violich Capital Management added most to CVS Health in Q1 2020, an estimated $497K increase.
- Violich Capital Management's biggest Q1 2020 reduction was Apple, cutting an estimated $1.48M.
- Violich Capital Management fully exited Vanguard Long-Term Bond ETF in Q1 2020, selling an estimated $4.93M.
- Violich Capital Management's ten largest holdings make up 53% of its $374M portfolio in Q1 2020.
- Violich Capital Management opened 5 new positions and closed 18 in Q1 2020.
- Violich Capital Management's portfolio value fell 18% quarter-over-quarter to $374M.
Based on Violich Capital Management's 13F filing for Q1 2020, filed 30 Apr 2020.